Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763

Clinical trial NCT01619332 · COMPLETED

Trial details

NCT number: NCT01619332
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type II Diabetes

Start date: 2012-03-01
Primary completion: 2013-09-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.